Tissue Bank Update – Resistant Tissue is Scarce
In recent years we have been able to gain valuable information from the data produced by tissue donations to the GIST Collaborative Tissue Bank.
Imatinib Rechallenge Impacts GIST Survival Rate
A recent nonrandomized study has shown that imatinib rechallenge impacted the survival rate for patients with advanced or metastatic gastrointestinal stromal tumor (GIST).
Drugs being Reconsidered to help Fight GIST
The LRG helped fund research by the University of Pittsburgh Cancer Institute (UPCI) to screen a library of FDA-approved anticancer drugs that previously wouldn’t have been considered as a treatment for GIST. UPCI scientists have been surprised at [...]
New Treatments on the Horizon for GIST?
There are two new treatments that may have an impact on fighting GIST – immunotherapy and MRI-guided radiation. The LRG is continually looking into new treatments for GIST.
GIST Research Campaign Q&A with Norman Scherzer
In December, the Life Raft Group launched its “We Are the Cure” campaign to fund GIST research. I sat down with Norman to find out more about The LRG GIST research team and the campaign’s progress to date.
2013 LRG Research Team Progress Report
Accomplishments—Recent Progress: 1. Using mouse models, successfully attacked GIST with antibodies, essentially telling immune system to eat the cancer cells.
LRG Launches Global Medical Team
The Life Raft Group is pleased to formally announce the creation of its first ever Global Medical Team. This team, which consists of leading physicians throughout the world, will provide the LRG the opportunity to [...]
The Life Raft Group Attends 18th Annual CTOS Meeting in NYC
From October 30th to November 2nd the Life Raft Group staff members attended the annual Connective Tissue Oncology Society (CTOS) Meeting in NYC.
AACR Releases 2013 Cancer Progress Report
The AACR has released it's 2013 Cancer Progress report. The report is a comprehensive educational tool that illustrates the return on investments in cancer research and biomedical science. It discusses the various ways medical teams continue [...]
Immunotherapeutic Approaches to Cancer
With the advent of Imatinib, tremendous progress has been made in the treatment of patients with GIST.